Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association

References

• Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens. 1999;12(4):205S–213S.
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–1916.
   PubMed Web of Science ®Google Scholar
• Stowasser M, Taylor PJ, Pimenta E, et al. Laboratory investigation of primary aldosteronism. Clin Biochem Rev. 2010;31(2):39–56. Cited: in:: PMID: 20498828.
   PubMedGoogle Scholar
• Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the american heart association. Hypertension. 2018;72(5):e53–e90. Cited: in:: PMID: 30354828.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40(6):892–896.
   PubMed Web of Science ®Google Scholar
• Williams TA, Reincke M. Management of endocrine disease: diagnosis and management of primary aldosteronism: the endocrine society guideline 2016 revisited. Eur J Endocrinol. 2018;179(1):R19–R29. Cited: in:: PMID: 29674485.
   PubMed Web of Science ®Google Scholar
• Ahmed AH, Gordon RD, Taylor PJ, et al. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J Clin Endocrinol Metab. 2011;96(6):1797–1804.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Mawet M, et al. Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception. 2021;103(4):213–221.
   PubMed Web of Science ®Google Scholar
• Lőcsei Z, Horváth D, Rácz K, et al. Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio. Clin Biochem. 2012;45(16–17):1516–1518.
   PubMed Web of Science ®Google Scholar
• Giribela CRG, Consolim-Colombo FM, Nisenbaum MG, et al. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women. Gynecological Endocrinol. 2015;31(11):912–915. Cited: in:: PMID: 26172927.
   PubMed Web of Science ®Google Scholar
• Le Goff CM, Gonzalez-Antuña A, Peeters SD, et al. Migration from RIA to LC-MS/MS for aldosterone determination: implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects. Clin Mass Spectrom. 2018;9:7–17.
   Google Scholar
• Raizman JE, Diamandis EP, Holmes D, et al. A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. Clin Chem. 2015;61(8):1022–1027. Cited: in:: PMID: 26106077.
   PubMed Web of Science ®Google Scholar
• Kfoury B, Cohen JB. Elevated renin and aldosterone levels in a young woman with hypertension. Am J Kidney Diseases. 2020;75(6):A11–A13. Cited: in:: PMID: 32446415.
   PubMed Web of Science ®Google Scholar
• Oelkers W, Blümel A, Schöneshöfer M, et al. Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men. J Clin Endocrinol Metab. 1976;43(5):1036–1040. Cited: in:: PMID: 993310.
   PubMed Web of Science ®Google Scholar
• Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol. 2004;217(1–2):255–261.
   PubMed Web of Science ®Google Scholar
• Blode H, Wuttke W, Loock W, et al. A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers. Eur J Contracept Reprod Health Care. 2000;5(4):256–264. Cited: in:: PMID: 11245553.
   PubMedGoogle Scholar
• Chapman AB, Zamudio S, Woodmansee W, et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol. 1997;273(5):F777–782. Cited: in:: PMID: 9374841.
   PubMed Web of Science ®Google Scholar
• Pizzolo F, Pavan C, Corrocher R, et al. Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. Am J Hypertens. 2007;20(12):1334–1337.
   PubMed Web of Science ®Google Scholar